Variant report

Variant	nsv970552
Chromosome Location	chr7:96654892-96655988
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	CTBP2	chr7:96655258-96656079	H1-hESC	embryonic stem cell:	n/a	n/a
2	CTCF	chr7:96655900-96656050	GM12873	blood:	n/a	n/a
3	CTCF	chr7:96655960-96656110	HUVEC	blood vessel:	n/a	n/a
4	CTCF	chr7:96655700-96655850	GM12867	blood:	n/a	n/a
5	POLR2A	chr7:96655189-96656411	H1-neurons	neurons:	n/a	n/a
6	POLR2A	chr7:96655396-96656178	H1-neurons	neurons:	n/a	n/a
7	POLR2A	chr7:96655282-96655929	K562	blood:	n/a	n/a
8	RAD21	chr7:96655299-96657631	SK-N-SH	brain:	n/a	chr7:96655925-96655938 chr7:96657146-96657165
9	REST	chr7:96624507-96656402	H1-neurons	neurons:	n/a	chr7:96626900-96626913 chr7:96628274-96628287 chr7:96653242-96653252 chr7:96638441-96638449 chr7:96644780-96644790 chr7:96627625-96627635 chr7:96628223-96628236 chr7:96655951-96655958 chr7:96625513-96625526 chr7:96635204-96635222 chr7:96634677-96634690 chr7:96628302-96628315 chr7:96652071-96652084 chr7:96650634-96650647 chr7:96628298-96628318 chr7:96628298-96628318
10	RUNX3	chr7:96655562-96655787	GM12878	blood:	n/a	chr7:96655747-96655756 chr7:96655747-96655756
11	SMC3	chr7:96655723-96655738	K562	blood:	n/a	n/a
12	SUZ12	chr7:96655000-96657260	H1-hESC	embryonic stem cell:	n/a	n/a

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr7:96655798-96655848	SAEC	small airway:	n/a
2	chr7:96655105-96655155	AG09319	gingival:	n/a
3	chr7:96655798-96655848	SAEC	small airway:	n/a
4	chr7:96655105-96655155	AG09319	gingival:	n/a
5	chr7:96655105-96655155	HRPEpiC	eye:	n/a
6	chr7:96655798-96655848	K562	blood:	n/a
7	chr7:96654931-96654981	NHDF-neo	bronchial:	n/a
8	chr7:96654931-96654981	NT2-D1	testis:	n/a
9	chr7:96655444-96655494	PrEC	prostate:	n/a
10	chr7:96655501-96655551	HepG2	liver:	n/a
11	chr7:96655798-96655848	ProgFib	skin:	n/a
12	chr7:96655501-96655551	HUVEC	blood vessel:	n/a
13	chr7:96655044-96655094	HCT-116	colon:	n/a
14	chr7:96655566-96655616	SKMC	muscle:	n/a
15	chr7:96655501-96655551	HRE	kidney:	n/a
16	chr7:96655501-96655551	GM06990	blood:	n/a
17	chr7:96654931-96654981	GM12891	blood:	n/a
18	chr7:96655566-96655616	MCF10A-Er-Src	breast:	n/a
19	chr7:96655105-96655155	K562	blood:	n/a
20	chr7:96655566-96655616	HEEpiC	esophagus:	n/a
21	chr7:96655566-96655616	HEK293	kidney:	embryo
22	chr7:96655444-96655494	HMEC	breast:	n/a
23	chr7:96655889-96655939	IMR90	lung:	fetal
24	chr7:96655981-96656031	HEEpiC	esophagus:	n/a
25	chr7:96655889-96655939	HCT-116	colon:	n/a
26	chr7:96654931-96654981	HUVEC	blood vessel:	n/a
27	chr7:96654931-96654981	NH-A	brain:	n/a
28	chr7:96655105-96655155	ProgFib	skin:	n/a
29	chr7:96654931-96654981	ECC-1	luminal epithelium:	n/a
30	chr7:96655044-96655094	RPTEC	kidney:	n/a
31	chr7:96655889-96655939	NT2-D1	testis:	n/a
32	chr7:96655798-96655848	AG10803	skin:	n/a
33	chr7:96655889-96655939	PFSK-1	brain:	n/a
34	chr7:96654931-96654981	HEEpiC	esophagus:	n/a
35	chr7:96655566-96655616	GM12892	blood:	n/a
36	chr7:96655566-96655616	BE2_C	brain:	n/a
37	chr7:96655044-96655094	Caco-2	colon:	n/a
38	chr7:96655798-96655848	HAEpiC	amniotic membrane:	n/a
39	chr7:96655105-96655155	U87	brain:	n/a
40	chr7:96655981-96656031	AG09309	skin:	n/a
41	chr7:96654931-96654981	RPTEC	kidney:	n/a
42	chr7:96655105-96655155	HNPCEpiC	eye:	n/a
43	chr7:96655981-96656031	HIPEpiC	eye:	n/a
44	chr7:96655798-96655848	AG04450	lung:	fetal
45	chr7:96655981-96656031	SKMC	muscle:	n/a
46	chr7:96655566-96655616	GM06990	blood:	n/a
47	chr7:96655566-96655616	HRE	kidney:	n/a
48	chr7:96655981-96656031	GM06990	blood:	n/a
49	chr7:96655798-96655848	MCF10A-Er-Src	breast:	n/a
50	chr7:96655798-96655848	NHDF-neo	bronchial:	n/a

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr7:95543308..95544949-chr7:96654875..96656626,2	MCF-7	breast:

Variant related genes	Relation type
DLX5	TF binding region
DLX5	CpG island

Extended variants
information (count: 49 )
Associated
traits (count: 77 )

Variant overlapped rSNPs/rCNVs (count:49 , 50 per page) page: 1

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs185939358	chr7:96654906-96654907	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Bivalent/Poised TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
2	rs115839710	chr7:96654908-96654909	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Bivalent/Poised TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
3	rs190257586	chr7:96654928-96654929	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Bivalent/Poised TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
4	rs139553906	chr7:96654935-96654936	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Bivalent/Poised TSS	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
5	rs117901163	chr7:96654988-96654989	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Bivalent/Poised TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
6	rs1526086	chr7:96655003-96655004	Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Weak transcription Flanking Active TSS Bivalent/Poised TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
7	rs574692109	chr7:96655011-96655012	Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Weak transcription Flanking Active TSS Bivalent/Poised TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
8	rs6975750	chr7:96655014-96655015	Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Weak transcription Flanking Active TSS Bivalent/Poised TSS	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
9	rs560150894	chr7:96655074-96655075	Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Weak transcription Flanking Active TSS Bivalent/Poised TSS	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
10	rs182671220	chr7:96655113-96655114	Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Weak transcription Flanking Active TSS Bivalent/Poised TSS	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
11	rs551728987	chr7:96655157-96655158	Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Weak transcription Flanking Active TSS Bivalent/Poised TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
12	rs562271626	chr7:96655161-96655162	Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Weak transcription Flanking Active TSS Bivalent/Poised TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
13	rs143377569	chr7:96655202-96655203	Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Bivalent/Poised TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
14	rs550934705	chr7:96655203-96655204	Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Bivalent/Poised TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
15	rs186955887	chr7:96655258-96655259	Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Bivalent/Poised TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
16	rs192266084	chr7:96655282-96655283	Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Bivalent/Poised TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
17	rs376636935	chr7:96655291-96655292	Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Bivalent/Poised TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
18	rs199916526	chr7:96655313-96655314	Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Bivalent/Poised TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
19	rs184168986	chr7:96655318-96655319	Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Bivalent/Poised TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
20	rs188830014	chr7:96655331-96655332	Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Bivalent/Poised TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
21	rs3956981	chr7:96655355-96655356	Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Bivalent/Poised TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
22	rs558974277	chr7:96655362-96655363	Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Bivalent/Poised TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
23	rs193211794	chr7:96655365-96655366	Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Bivalent/Poised TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
24	rs550391413	chr7:96655501-96655502	Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Weak transcription Bivalent/Poised TSS Active TSS	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
25	rs538340733	chr7:96655519-96655520	Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Weak transcription Bivalent/Poised TSS Active TSS	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
26	rs554720587	chr7:96655525-96655526	Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Weak transcription Bivalent/Poised TSS Active TSS	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
27	rs184335150	chr7:96655538-96655539	Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Weak transcription Bivalent/Poised TSS Active TSS	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
28	rs79464991	chr7:96655550-96655551	Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Weak transcription Bivalent/Poised TSS Active TSS	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
29	rs529508852	chr7:96655565-96655566	Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Weak transcription Bivalent/Poised TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
30	rs73404547	chr7:96655579-96655580	Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Weak transcription Bivalent/Poised TSS Active TSS	TF binding region CpG island	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
31	rs576705640	chr7:96655587-96655588	Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Weak transcription Bivalent/Poised TSS Active TSS	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
32	rs545429729	chr7:96655600-96655601	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer Enhancers Weak transcription Active TSS	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
33	rs562135346	chr7:96655682-96655683	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Enhancers Bivalent Enhancer Weak transcription Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
34	rs188916679	chr7:96655698-96655699	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Enhancers Bivalent Enhancer Weak transcription Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
35	rs548274864	chr7:96655710-96655711	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Enhancers Bivalent Enhancer Weak transcription Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
36	rs561594492	chr7:96655724-96655725	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Enhancers Bivalent Enhancer Weak transcription Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
37	rs1207735	chr7:96655726-96655727	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Enhancers Bivalent Enhancer Weak transcription Active TSS	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
38	rs546855114	chr7:96655750-96655751	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Enhancers Bivalent Enhancer Weak transcription Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
39	rs567202500	chr7:96655770-96655771	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Enhancers Bivalent Enhancer Weak transcription Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
40	rs557696283	chr7:96655799-96655800	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Enhancers Bivalent Enhancer Weak transcription Active TSS	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
41	rs569986015	chr7:96655817-96655818	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Weak transcription Active TSS Flanking Active TSS	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
42	rs555813099	chr7:96655827-96655828	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Weak transcription Active TSS Flanking Active TSS	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
43	rs532843722	chr7:96655857-96655858	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Weak transcription Active TSS Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
44	rs115203738	chr7:96655874-96655875	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Weak transcription Active TSS Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
45	rs536691038	chr7:96655890-96655891	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Weak transcription Active TSS Flanking Active TSS	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
46	rs569280303	chr7:96655904-96655905	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Weak transcription Active TSS Flanking Active TSS	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
47	rs537812194	chr7:96655912-96655913	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Weak transcription Active TSS Flanking Active TSS	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
48	rs555064493	chr7:96655938-96655939	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Weak transcription Active TSS Flanking Active TSS	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
49	rs568436823	chr7:96655965-96655966	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Weak transcription Active TSS Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:77)

Disease	PMID	Source
Basal cell lymphoma	17170743	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Thyroid cancer	19087340	CNVD
Seminomas	18059402	CNVD
Testicular cancer	18059402	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Autism	19415332	CNVD
Medulloblastoma	21979893	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
T-cell lymphomas	19863542	CNVD
Malaria	21533027	CNVD
Melanoma	18172304	CNVD
Renal cell carcinoma	19461508	CNVD
head and neck squamous cell carcinoma	19289630	CNVD
Stenocardia	21860640	CNVD
Vasospasm	21860640	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Ewing''s sarcoma	17952124	CNVD
Autism	22495311	CNVD
Wilms tumour	21544195	CNVD
Glioblastoma multiforme	21750150	CNVD
Cancer	21183584	CNVD
Hepatocellular carcinoma	16750200	CNVD
Non-small cell lung cancer	21829676	CNVD
Gastric cancer	24379144	CNVD
Glioblastoma multiforme	17002787	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Lissencephaly	21572526	CNVD
Breast cancer	17603634	CNVD
Liposarcoma	21253554	CNVD
Breast cancer	16397240	CNVD
Acute myeloid leukemia	16864856	CNVD
Squamous cell cancer	21044232	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Astrocytoma	17387387	CNVD
Glioblastoma multiforme	17387387	CNVD
Low-grade fibromyxoid sarcoma	0	CNVD
Oligodendroglial tumors	17285580	CNVD
Endometrial cancer	22040021	CNVD
Burkitt''s lymphoma	18698080	CNVD
Breast cancer	21264507	CNVD
Shwachman-Diamond syndrome	22934832	CNVD
Colorectal cancer	19359472	CNVD
Cutaneous malignant melanoma	17690212	CNVD
Leukemia	17361228	CNVD
Breast cancer	16461572	CNVD
Peripheral t-cell lymphoma	19118030	CNVD
Malignant melanoma	17690212	CNVD
Renal cell carcinoma	18592004	CNVD
Acute promyelocytic leukemia	19109227	CNVD
Multiple myeloma	17550852	CNVD
small cell lung cancer	20016488	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Neurodevelopmental disorder	22521361	CNVD
Metanephric adenoma	20802469	CNVD
abortions and stillbirths	19751515	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
Acute myeloid leukemia	20729466	CNVD
Lung cancer	18438408	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Schizophrenia	17879154	CNVD
Prostate cancer	16573809	CNVD
Prostate cancer	16461572	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Autism	20858243	CNVD
Non-syndromic sensorineural hearing loss	21987784	CNVD
Burkitt''s lymphoma	19759907	CNVD
Malignant melanoma	17260012	CNVD
Myoclonus-dystonia	17898012	CNVD
Myelodysplastic syndrome	21251322	CNVD
Cancer	20164920	CNVD
abnormal development	18461090	CNVD
Acute myeloid leukemia	21251322	CNVD
Breast cancer	21785460	CNVD
Myelofibrosis	22110671	CNVD

Chromatin state (count:147 , 50 per page) page: 1 2 3

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr7:96647000-96655200	Bivalent/Poised TSS	Brain Germinal Matrix	brain
2	chr7:96653200-96656600	Bivalent Enhancer	Primary T cells fromperipheralblood	blood
3	chr7:96654000-96657200	Bivalent Enhancer	Fetal Brain Male	brain
4	chr7:96654200-96655400	Flanking Active TSS	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
5	chr7:96654200-96655400	Bivalent Enhancer	Brain Hippocampus Middle	brain
6	chr7:96654200-96655600	Weak transcription	Gastric	stomach
7	chr7:96654200-96655600	Weak transcription	Pancreas	Pancrea
8	chr7:96654200-96656800	Bivalent Enhancer	ES-UCSF4 Cell Line	embryonic stem cell
9	chr7:96654400-96655600	Weak transcription	Right Ventricle	heart
10	chr7:96654400-96657200	Bivalent/Poised TSS	Fetal Brain Female	brain
11	chr7:96654600-96655200	Bivalent Enhancer	ES-I3 Cell Line	embryonic stem cell
12	chr7:96654600-96655200	Bivalent Enhancer	H9 Cell Line	embryonic stem cell
13	chr7:96654600-96655200	Bivalent Enhancer	HUES6 Cell Line	embryonic stem cell
14	chr7:96654600-96655200	Bivalent Enhancer	Fetal Lung	lung
15	chr7:96654600-96655400	Bivalent Enhancer	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
16	chr7:96654600-96655400	Bivalent Enhancer	HUES48 Cell Line	embryonic stem cell
17	chr7:96654600-96655400	Weak transcription	Right Atrium	heart
18	chr7:96654600-96655600	Bivalent Enhancer	H1 Cell Line	embryonic stem cell
19	chr7:96654600-96655600	Enhancers	Ovary	ovary
20	chr7:96654600-96657000	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
21	chr7:96654800-96655000	Bivalent Enhancer	iPS-15b Cell Line	embryonic stem cell
22	chr7:96654800-96655400	Bivalent Enhancer	HUES64 Cell Line	embryonic stem cell
23	chr7:96654800-96655400	Bivalent/Poised TSS	Ganglion Eminence derived primary cultured neurospheres	brain
24	chr7:96654800-96655600	Bivalent Enhancer	iPS-18 Cell Line	embryonic stem cell
25	chr7:96654800-96656400	Weak transcription	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
26	chr7:96654800-96656600	Weak transcription	Osteobl	bone
27	chr7:96655000-96655600	Flanking Bivalent TSS/Enh	iPS-15b Cell Line	embryonic stem cell
28	chr7:96655000-96655800	Bivalent Enhancer	Primary T helper memory cells from peripheral blood 2	blood
29	chr7:96655200-96655400	Bivalent Enhancer	Primary T cells from cord blood	blood
30	chr7:96655200-96655600	Bivalent Enhancer	Primary T killer memory cells from peripheral blood	blood
31	chr7:96655200-96655600	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Male	--
32	chr7:96655200-96655600	Flanking Bivalent TSS/Enh	Brain Germinal Matrix	brain
33	chr7:96655200-96655600	Bivalent Enhancer	Colon Smooth Muscle	Colon
34	chr7:96655200-96655800	Flanking Bivalent TSS/Enh	ES-I3 Cell Line	embryonic stem cell
35	chr7:96655200-96655800	Bivalent Enhancer	Colonic Mucosa	Colon
36	chr7:96655200-96656200	Flanking Bivalent TSS/Enh	HUES6 Cell Line	embryonic stem cell
37	chr7:96655200-96656200	Flanking Bivalent TSS/Enh	iPS-20b Cell Line	embryonic stem cell
38	chr7:96655200-96656200	Bivalent Enhancer	Primary T killer naive cells fromperipheralblood	blood
39	chr7:96655200-96656400	Bivalent Enhancer	Primary T helper cells PMA-I stimulated	--
40	chr7:96655200-96656800	Bivalent Enhancer	Primary mononuclear cells fromperipheralblood	Blood
41	chr7:96655200-96657200	Bivalent/Poised TSS	Brain Angular Gyrus	brain
42	chr7:96655400-96655600	Flanking Bivalent TSS/Enh	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
43	chr7:96655400-96655600	Flanking Bivalent TSS/Enh	HUES48 Cell Line	embryonic stem cell
44	chr7:96655400-96655600	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
45	chr7:96655400-96655600	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Female	--
46	chr7:96655400-96655600	Bivalent Enhancer	Ganglion Eminence derived primary cultured neurospheres	brain
47	chr7:96655400-96655600	Bivalent Enhancer	Liver	Liver
48	chr7:96655400-96655600	Bivalent Enhancer	Brain Anterior Caudate	brain
49	chr7:96655400-96655600	Bivalent Enhancer	Brain Dorsolateral Prefrontal Cortex	brain
50	chr7:96655400-96655600	Bivalent Enhancer	Rectal Smooth Muscle	rectum

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links